{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:24:53Z","timestamp":1793049893563,"version":"4.5.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T00:00:00Z","timestamp":1660780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T00:00:00Z","timestamp":1660780800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s00198-022-06534-4","type":"journal-article","created":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T08:02:54Z","timestamp":1660809774000},"page":"2649-2652","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Romosozumab successfully regulated progressive osteoporosis in a patient with autosomal dominant polycystic kidney disease undergoing hemodialysis"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9531-7814","authenticated-orcid":false,"given":"Taihei","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahide","family":"Mizobuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narumi","family":"Terado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shugo","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nozomi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Honda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,18]]},"reference":[{"key":"6534_CR1","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/S2213-8587(17)30188-2","volume":"5","author":"S Khosla","year":"2017","unstructured":"Khosla S, Hofbauer LC (2017) Osteoporosis treatment: recent developments and ongoing challenges. Lancet Diabetes Endocrinol 5:898\u2013907","journal-title":"Lancet Diabetes Endocrinol"},{"key":"6534_CR2","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.1681\/ASN.2005111194","volume":"17","author":"TL Nickolas","year":"2006","unstructured":"Nickolas TL, McMahon DJ, Shane E (2006) Relationship between moderate to severe kidney disease and hip fracture in the United States. J Am Soc Nephrol 17:3223\u20133232","journal-title":"J Am Soc Nephrol"},{"key":"6534_CR3","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s00223-021-00874-9","volume":"109","author":"L Aaltonen","year":"2021","unstructured":"Aaltonen L, Koivuviita N, Sepp\u00e4nen M et al (2021) Bone histomorphometry and 18F-sodium fluoride positron emission tomography imaging: comparison between only bone turnover-based and unified TMV-based classification of renal osteodystrophy. Calcif Tissue Int 109:605\u2013614","journal-title":"Calcif Tissue Int"},{"key":"6534_CR4","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nrendo.2013.137","volume":"9","author":"C Sobacchi","year":"2013","unstructured":"Sobacchi C, Schulz A, Coxon FP, Villa A, Helfrich MH (2013) Osteopetrosis: genetics, treatment and new insights into osteoclast function. Nat Rev Endocrinol 9:522\u2013536","journal-title":"Nat Rev Endocrinol"},{"key":"6534_CR5","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1002\/jbmr.3735","volume":"34","author":"P Chavassieux","year":"2019","unstructured":"Chavassieux P, Chapurlat R, Portero-Muzy N et al (2019) Bone-forming and antiresorptive effects of romosozumab in postmenopausal women with osteoporosis: bone histomorphometry and microcomputed tomography analysis after 2 and 12 months of treatment. J Bone Miner Res 34:1597\u20131608","journal-title":"J Bone Miner Res"},{"key":"6534_CR6","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s12325-021-01936-y","volume":"39","author":"DL Kendler","year":"2022","unstructured":"Kendler DL, Cosman F, Stad RK, Ferrari S (2022) Denosumab in the treatment of osteoporosis: 10 years later: a narrative review. Adv Ther 39:58\u201374","journal-title":"Adv Ther"},{"key":"6534_CR7","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1038\/s41598-020-59143-8","volume":"10","author":"K Kunizawa","year":"2020","unstructured":"Kunizawa K, Hiramatsu R, Hoshino J et al (2020) Denosumab for dialysis patients with osteoporosis: a cohort study. Sci Rep 10:2496","journal-title":"Sci Rep"},{"key":"6534_CR8","doi-asserted-by":"publisher","first-page":"787","DOI":"10.3390\/jcm10040787","volume":"10","author":"M Rauner","year":"2021","unstructured":"Rauner M, Taipaleenm\u00e4ki H, Tsourdi E, Winter EM (2021) Osteoporosis treatment with anti-sclerostin antibodies-mechanisms of action and clinical application. J Clin Med 10:787","journal-title":"J Clin Med"},{"key":"6534_CR9","doi-asserted-by":"publisher","first-page":"5525","DOI":"10.3390\/ijms20225525","volume":"20","author":"K Maeda","year":"2019","unstructured":"Maeda K, Kobayashi Y, Koide M et al (2019) The regulation of bone metabolism and disorders by Wnt signaling. Int J Mol Sci 20:5525","journal-title":"Int J Mol Sci"},{"key":"6534_CR10","doi-asserted-by":"crossref","unstructured":"Weivoda MM, Ruan M, Hachfeld CM et al (2016) Wnt signaling inhibits osteoclast differentiation by activating canonical and noncanonical cAMP\/PKA pathways. J Bone Miner Res 31:65\u201375 [published correction appears in J Bone Miner Res. 2019 Aug; 34: 1546\u20131548]","DOI":"10.1002\/jbmr.2599"},{"key":"6534_CR11","doi-asserted-by":"publisher","first-page":"3261","DOI":"10.1007\/s10067-020-04948-1","volume":"39","author":"S Kaveh","year":"2020","unstructured":"Kaveh S, Hosseinifard H, Ghadimi N, Vojdanian M, Aryankhesal A (2020) Efficacy and safety of Romosozumab in treatment for low bone mineral density: a systematic review and meta-analysis. Clin Rheumatol 39:3261\u20133276","journal-title":"Clin Rheumatol"},{"key":"6534_CR12","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1007\/s00774-021-01253-y","volume":"39","author":"M Sato","year":"2021","unstructured":"Sato M, Inaba M, Yamada S, Emoto M, Ohno Y, Tsujimoto Y (2021) Efficacy of romosozumab in patients with osteoporosis on maintenance hemodialysis in Japan; an observational study. J Bone Miner Metab 39:1082\u20131090","journal-title":"J Bone Miner Metab"},{"issue":"12 Pt 2","key":"6534_CR13","doi-asserted-by":"publisher","first-page":"S147","DOI":"10.1301\/nr.2007.dec.S147-S151","volume":"65","author":"GR Mundy","year":"2007","unstructured":"Mundy GR (2007) Osteoporosis and inflammation. Nutr Rev 65(12 Pt 2):S147-151","journal-title":"Nutr Rev"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-022-06534-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-022-06534-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-022-06534-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T09:08:52Z","timestamp":1668157732000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-022-06534-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,18]]},"references-count":13,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["6534"],"URL":"https:\/\/doi.org\/10.1007\/s00198-022-06534-4","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,18]]},"assertion":[{"value":"2 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work follows the guideline of ethic committee in Showa University School of Medicine.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare that the patient in this report agrees with the usage of his medical data for the research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}